Clinical Trials in Lansing, United States
Locations / Lansing, United States
Delta Trials hosts 1,265 clinical trials conducted in Lansing, United States, making it a notable site of clinical research activity. These trials covering 2,166 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 140 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Lansing.
1265
Total Trials
2166
Conditions
140
Terminated since 2020
Browse by condition (2166 total)
- Breast cancer 68 trialsAll Breast cancer trials
- Rheumatoid arthritis 62 trialsAll Rheumatoid arthritis trials
- Lung cancer 31 trialsAll Lung cancer trials
- Heart failure 28 trialsAll Heart failure trials
- Prostate cancer 26 trialsAll Prostate cancer trials
- Atrial fibrillation 25 trialsAll Atrial fibrillation trials
- Systemic lupus erythematosus 23 trialsAll Systemic lupus erythematosus trials
- Psoriatic arthritis 23 trialsAll Psoriatic arthritis trials
- Leukemia 21 trialsAll Leukemia trials
- Stage iv lung cancer ajcc v8 20 trialsAll Stage iv lung cancer ajcc v8 trials
- Multiple myeloma 19 trialsAll Multiple myeloma trials
- Lymphoma 18 trialsAll Lymphoma trials
- Colorectal cancer 16 trialsAll Colorectal cancer trials
- Arthritis, rheumatoid 16 trialsAll Arthritis, rheumatoid trials
- Coronary artery disease 16 trialsAll Coronary artery disease trials
- Recurrent ovarian carcinoma 15 trialsAll Recurrent ovarian carcinoma trials
- All Unspecified adult solid tumor, protocol specific trials
- Stroke 14 trialsAll Stroke trials
- Recurrent lung non-small cell carcinoma 13 trialsAll Recurrent lung non-small cell carcinoma trials
- Recurrent fallopian tube carcinoma 12 trialsAll Recurrent fallopian tube carcinoma trials